Atlas Trials

CRP Regimen in Treating Elderly Patients With Previously Untreated Double-Positive DLBCL

Clinical trial NCT07397832 · RECRUITING

Trial details

NCT number
NCT07397832
Sponsor
Tianjin Medical University Cancer Institute and Hospital
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Diffuse Large B-Cell Lymphoma (DLBCL)
Start date
2026-02-03
Primary completion
2028-07-30
Enrollment
58

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.